The HWI group is an innovative service provider for Pharma, Biotech & Medtech
The HWI group offers a broad range of individual and specialised pharmaceutical services for the pharma, biotech and medtech sector, particularly for active ingredients, medicinal products and medical devices. Benefit from our long-standing experience in laboratory services, vigilance and quality services, drug development as well as regulatory affairs services.
With 180 colleagues at 4 sites in Ruelzheim, Frankfurt, Appenweier and Planegg (near Munich) we look back on 30 years of experience.
We offer a service portfolio ranging from product development, analytical development and quality control, manufacturing of clinical batches and smaller market batches to regulatory, drug safety and GxP services.
Together with network partners, HWI also supports clinical and preclinical studies.
Our technology platform for parenteral, nasal and oral applications focuses on the development of innovative and affordable drugs with a special focus on poorly soluble small and large molcules.
Our purpose is with novel technologies and innovative services to drive the development of highly effective medicines for everyone to improve peoples lives.
Code of Business Conduct
The reputation of the HWI group, the trust in us as business partners and the sustainable success of our company are important to us. Values such as personal responsibility, integrity and transparency, as well as legally compliant and ethically correct behaviour at all times; they are firmly established in our daily actions and in our corporate culture.
Our Code of Conduct reflects the standards we set for ourselves, our owners, our directors, our managers and each of our employees. It serves as a guideline, provides orientation and defines our basic rules and principles.
